Metabolic syndrome and nonalcoholic fatty liver disease. The role of endothelial progenitor cells

• Published in: Annals of hepatology Vol. 12; no. 6; pp. 908 - 914
• Main Authors: Gutiérrez-Grobe, Ylse, Gavilanes-Espinar, Juan G, Masso-Rojas, Felipe A, Sánchez-Valle, Vicente, Páez-Arenas, Araceli, Ponciano-Rodríguez, Guadalupe, Chávez-Tapia, Norberto C, Uribe, Misael, Méndez-Sánchez, Nahum
• Format: Journal Article
• Language: English
• Published: Mexico Elsevier 01-11-2013
• Subjects: AC133 Antigen; Antigens, CD - blood; Antigens, CD34 - blood; Biomarkers - blood; Cardiovascular risk; Case-Control Studies; Cross-Sectional Studies; Endothelial Cells - metabolism; Endothelial Cells - pathology; Endothelial progenitor cells; Endothelium; Fatty Liver - blood; Fatty Liver - pathology; Glycoproteins - blood; Hospitals, University; Humans; Insulin Resistance; Leukocyte Common Antigens - blood; Metabolic syndrome; Metabolic Syndrome - blood; Metabolic Syndrome - pathology; Mexico; Middle Aged; NAFLD; Non-alcoholic Fatty Liver Disease; Peptides - blood; Pilot Projects; Severity of Illness Index; Stem Cells - metabolism; Stem Cells - pathology; Vascular Endothelial Growth Factor Receptor-2 - blood
• ISSN: 1665-2681
• DOI: 10.1016/S1665-2681(19)31296-7

Endothelial dysfunction has been previously described in metabolic syndrome patients. The levels of circulating endothelial progenitor cells (EPCs) inversely correlates with the incidence of cardiovascular disease. The aim of this study was to investigate the association between NAFLD, metabolic syndrome and EPC levels.
A cross-sectional pilot study was performed at a university hospital in Mexico. Two groups of patients without previously known chronic diseases were studied and classified according to the presence of NAFLD. Anthropometric, dietary, and biochemical variables, and circulating EPC number were measured and compared between the groups.
Forty subjects were included and classified into two groups: patients with NAFLD (n = 20) and a control group (n = 20). The overall prevalence of insulin resistance and metabolic syndrome was 25% and 17.5%, respectively. EPC levels were found to be higher in the NAFLD group (p < 0.05) as in the patients with insulin resistance (p < 0.01) and metabolic syndrome (p < 0.01). These levels showed correlation with the severity of steatosis.
Patients with NAFLD have increased levels of EPC, such levels are associated with the severity of NAFLD. These findings may suggest that these cells may play a role in the early natural history of NAFLD. EPC might be increased in an attempt to repair the endothelial damage resulting from metabolic alterations accompanying NAFLD. Further studies are needed to establish the dynamics of these cells in NAFLD.